Healthcare Equipment and Supplies
Everyone should have some exposure to healthcare/biotechnology in their long-term portfolio. There are many exciting choices, ranging from big pharma to highly speculative biotech companies, so which is right for you? Believe it or not, my favorite for long-term growth and income is Johnson & Johnson (NYSE: JNJ), which has an undeserved reputation for being a boring investment.
About Johnson & Johnson
Johnson & Johnson is one of the largest healthcare companies more »
Every equity investment comes with its own set of risks. Evaluating those risks is an important step in determining the worthiness of a potential investment. Looking at pharmacy retailer Walgreen’s (NYSE: WAG) 2012 form 10K three risks stand out as especially relevant in determining Walgreen’s future as an investment.
It's time again to look ahead to the next year. We put together a 10 Stock list for 2012 at Fastball Financial and achieved so-so results (a gain for that group of stocks, but they still did not outperform the S&P 500 as a whole...we'll put out a separate review on that soon). Looking ahead to 2013, we see a continued strengthening in the economy, assuming more »
I am particularly smitten with health care penny stocks. Investing in so-called penny stocks is certainly attractive. But rampant speculation followed by investment in unregulated market can lead the portfolio to go haywire. Therefore extensive research and understanding the business is of real importance rather than being taken for a ride. Penny stocks have a solid reputation for being a risky investment; however, if the potential rewards excite you, then more »
Johnson & Johnson (NYSE: JNJ) had what amounts to a schizophrenic 2011, or maybe that should be manic depressive? Either way the company impressed in many ways and absolutely disappointed in others.
First the Good News
The majority of J&J revenue comes from international sales and as a $177 billion company it stands to reason they would have their fingers in several different pies. Today’s earnings announcement showed particularly more »
This morning I woke up with a strange thought. I wanted to know what the most expensive stock per share was in the world. Naturally, I turned to Google to find my answers, since perusing every stock everywhere didn't seem like a wise use of my time (and yet, it did sound intriguing). Using a few key search phrases, followed by checking today's ticker, I can hereby proclaim more »